Recent ACTU News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 08:43:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:15:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:04:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:03:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2026 08:02:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/14/2026 08:06:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 09:27:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:00:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2026 02:15:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 01:45:08 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/22/2026 07:24:29 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:04:02 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/06/2026 08:06:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/06/2026 08:06:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 09:19:31 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:00:51 PM
- Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers • ACCESS Newswire • 03/24/2026 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 09:00:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/11/2025 09:22:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2025 10:21:45 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/28/2025 10:19:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 09:30:42 PM
